Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting.

The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Abstract Text:

    lesli ann rawlesLesli Ann Rawles,diana acunaDiana Acuna,robert p ericksonRobert P Erickson,lesli ann rawlesLesli Ann Rawles,diana acunaDiana Acuna,robert p ericksonRobert P Erickson,

    Previous studies have shown a role for multiple drug resistance proteins in protecting the fetus from a limited number of teratogens. We have expanded the number of proteins and teratogens examined by comparing the influence of the mdr1a and mdr2 proteins on teratogen-induced orofacial clefting using their respective knockouts in crosses with the A/J, high susceptibility strain. Western blots identified the presence of mdr1a and possibly mdr2 in the placenta and fetus. The mdr1a knockout, on its unique genetic background showed lower, similar, and higher incidences of clefting compared to A/J for Dilantin, hydrocortisone (HC), and 6-aminonicotinamide (6-AN), respectively. The mdr2 knockout did not affect 6-AN clefting when compared to A/J. In reciprocal crosses, when corrected for increased spontaneous clefting, maternally inherited A/J susceptibility genes predominated over the effects of the maternal absence of mdr1a (with 6-AN). Unlike mdr1a, which had a direct effect in the fetus as shown by genotyping of affected versus unaffected fetuses, an effect of mdr2 in the fetus was not found. The mdr1a knockout was backcrossed to the A/J inbred strain for 11 generations (congenics) to eliminate genetic background effects. Reciprocal crosses showed no maternal effect from the lack of mdr1a, confirming that mdr1a expression in the fetus, rather than the placenta, protects the fetus from teratogens. Mdr2 seems not to be involved in the protection of the fetus from teratogens.

    The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Publishing Authors By Initials

    la rawlesLA Rawles,d acunaD Acuna,rp ericksonRP Erickson,la rawlesLA Rawles,d acunaD Acuna,rp ericksonRP Erickson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Molecular reproduction and development

    VOLUME: 74

    Page Numbers: 1483-9

    Journal Abbreviation: Mol. Reprod. Dev.

    ISSN: 1040-452X

    DAY: 4

    MONTH: Nov

    YEAR: 2007

    The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8903333

    The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting.

    AFFILIATION: Angel Charity for Children - Wings for Genetic Research, Steele Children's Research Center, Department of Pediatrics, Section of Medical and Molecular Genetics, University of Arizona, Tucson, Arizona, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIEHS

    GRANT: ES 10047

    ACRONYM: ES

    MEDLINETA: Mol Reprod Dev

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News